Mental and Behavioral Health

Latest News

Maintenance Use of ADHD Therapies May Be Safe in Pregnancy
Maintenance Use of ADHD Therapies May Be Safe in Pregnancy

November 18th 2024

Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia
Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

November 5th 2024

Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage
Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage

October 30th 2024

Pharmacy Screening Can Identify Depression in Older Adults
Pharmacy Screening Can Identify Depression in Older Adults

October 21st 2024

Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD
Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD

October 21st 2024

Latest CME Events & Activities

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

November 12, 2024 | 1:00 PM & 8:00 PM ET

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...

2.0 Credits / Neurology, Psychiatry

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements

2.0 Credits / Psychiatry

View More

Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia

3.0 Credits / Psychiatry

View More

<123456
© 2024 MJH Life Sciences

All rights reserved.